Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandrajit P Raut

Showing results (121-130 of 229) with videos related to

Pageof 23
Sort By:
BMC Cancer|December 31, 2018
Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: initial experience of molecularly targeted therapyRobert Nakayama, Jyothi Priya Jagannathan, Nikhil Ramaiya, et al.
Annals of Surgery|April 28, 2017
Cytoreductive Surgery for Metastatic Gastrointestinal Stromal Tumors Treated With Tyrosine Kinase Inhibitors: A 2-institutional AnalysisMark Fairweather, Vinod P Balachandran, George Z Li, et al.
Annals of Surgical Oncology|July 20, 2011
Paclitaxel-eluting polymer film reduces locoregional recurrence and improves survival in a recurrent sarcoma model: a novel investigational therapyRong Liu, Jesse B Wolinsky, Paul J Catalano, et al.
European Journal of Cancer (Oxford, England : 1990)|August 19, 2008
Multimodality treatment of mesenteric desmoid tumoursMonica M Bertagnolli, Jeffrey A Morgan, Christopher D M Fletcher, et al.
JAMA Oncology|November 2, 2018
Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor: The PERSIST-5 Clinical TrialChandrajit P Raut, N Joseph Espat, Robert G Maki, et al.
Journal of Surgical Oncology|June 19, 2026
New Paradigms of Cancer Require New Language: A Qualitative Study Exploring Language for Non-Curative Non-Palliative Cancer SurgeryBonnie O Wong, Orly N Farber, Amanda J Reich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitorsChandrajit P Raut, Matthew Posner, Jayesh Desai, et al.
The British Journal of Surgery|May 28, 2024
Primary pelvic soft tissue sarcomas (PELVISARC): outcomes from the TransAtlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Marco Fiore, Catherine Sarre-Lazcano, Myles Smith, et al.
Annals of Surgical Oncology|October 25, 2014
Safety and efficacy of radiation dose delivered via iodine-125 brachytherapy mesh implantation for deep cavity sarcomasMark Fairweather, Jiping Wang, Phillip M Devlin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Histologic Appearance After Preoperative Radiation Therapy for Soft Tissue Sarcoma: Assessment of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Response ScoreInga-Marie Schaefer, Jason L Hornick, Constance M Barysauskas, et al.
Pageof 23

Showing results (121-130 of 229) with videos related to

Sort By:
Pageof 23
BMC Cancer|December 31, 2018
Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: initial experience of molecularly targeted therapyRobert Nakayama, Jyothi Priya Jagannathan, Nikhil Ramaiya, et al.
Annals of Surgery|April 28, 2017
Cytoreductive Surgery for Metastatic Gastrointestinal Stromal Tumors Treated With Tyrosine Kinase Inhibitors: A 2-institutional AnalysisMark Fairweather, Vinod P Balachandran, George Z Li, et al.
Annals of Surgical Oncology|July 20, 2011
Paclitaxel-eluting polymer film reduces locoregional recurrence and improves survival in a recurrent sarcoma model: a novel investigational therapyRong Liu, Jesse B Wolinsky, Paul J Catalano, et al.
European Journal of Cancer (Oxford, England : 1990)|August 19, 2008
Multimodality treatment of mesenteric desmoid tumoursMonica M Bertagnolli, Jeffrey A Morgan, Christopher D M Fletcher, et al.
JAMA Oncology|November 2, 2018
Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor: The PERSIST-5 Clinical TrialChandrajit P Raut, N Joseph Espat, Robert G Maki, et al.
Journal of Surgical Oncology|June 19, 2026
New Paradigms of Cancer Require New Language: A Qualitative Study Exploring Language for Non-Curative Non-Palliative Cancer SurgeryBonnie O Wong, Orly N Farber, Amanda J Reich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitorsChandrajit P Raut, Matthew Posner, Jayesh Desai, et al.
The British Journal of Surgery|May 28, 2024
Primary pelvic soft tissue sarcomas (PELVISARC): outcomes from the TransAtlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Marco Fiore, Catherine Sarre-Lazcano, Myles Smith, et al.
Annals of Surgical Oncology|October 25, 2014
Safety and efficacy of radiation dose delivered via iodine-125 brachytherapy mesh implantation for deep cavity sarcomasMark Fairweather, Jiping Wang, Phillip M Devlin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Histologic Appearance After Preoperative Radiation Therapy for Soft Tissue Sarcoma: Assessment of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Response ScoreInga-Marie Schaefer, Jason L Hornick, Constance M Barysauskas, et al.
Pageof 23